Business Context and Reporting Period
This Form 8-K, filed on October 27, 2014, by Crane Co. (not Crane NXT, Co.), reports the results of operations for the quarter ended September 30, 2014. The filing primarily details the company's ongoing asbestos liability exposure, litigation status, and financial estimates related to tort claims.
Key Financial Metrics: Asbestos Liability and Costs
The filing provides specific data regarding asbestos-related costs and liabilities, though it does not contain general revenue, profit, or cash flow figures for the company's core operations (referenced in attached exhibits not included in the text).
- Total Asbestos Liability: $637 million as of September 30, 2014 (down from $894 million recorded in 2011).
- Current Portion of Liability: $88 million (estimated costs to be paid within 12 months).
- Insurance Receivable Asset: $155 million as of September 30, 2014 (estimated probable reimbursement).
- Cumulative Resolved Claims: Approximately 106,000 claims resolved through September 30, 2014, with total settlement costs of approximately $418 million.
- Average Settlement Cost: Approximately $4,000 per resolved claim cumulatively.
Asbestos Costs Incurred vs. Cash Payments (Nine Months Ended Sept 30, 2014)
| Item | 2014 (in millions) | 2013 (in millions) |
|---|---|---|
| Total Costs Incurred (Settlement + Defense) | $61.4 | $67.9 |
| Pre-tax Cash Payments (Net of Insurance) | $46.2 | $48.3 |
| Settlement/Indemnity Costs Incurred | $18.5 | $23.2 |
| Defense Costs Incurred | $43.0 | $44.7 |
Material Changes and Litigation Activity
Claim Volume: As of September 30, 2014, there were 47,922 pending asbestos claims, a decrease from 53,822 in the prior year. New claims filed in the nine months ended September 30, 2014, totaled 2,078, compared to 2,207 in the prior year period.
Liability Estimate Stability: Management determined that no change to the asbestos liability estimate was warranted for the period ended September 30, 2014. The estimate covers claims filed or projected through 2021. The company notes that actual experience with mesothelioma claims generally approximated the assumptions in the liability estimate.
Significant Verdicts and Appeals:
- William Paulus (CA): Paid $0.9 million in June 2014 after exhausting appeals.
- Ronald Dummitt (NY): Judgment affirmed at $4.9 million; appeal pending at NY Court of Appeals.
- Gerald Suttner (NY): Judgment affirmed at $0.1 million; review accepted by NY Court of Appeals in Q4 2014.
- James Nelson (PA): Verdict vacated by Superior Court; en banc reargument heard in Q3 2014.
- Recent Verdicts: Adverse verdicts entered in Q3/Q4 2014 include Ivan Sweberg ($15M) and Selwyn Hackshaw ($10M) in NY, and Lloyd Garvin ($11M compensatory + $11M exemplary) in SC. These amounts are not included in incurred costs until appeals are exhausted.
Outlook, Risks, and Contingencies
Forecast Period: The liability estimate covers claims through 2021. Management believes it is not possible to reasonably estimate costs beyond 2021 due to uncertainty regarding future claim volumes and costs.
Insurance Coverage: The company has "coverage-in-place" agreements with 11 excess insurer groups and policy buyout agreements totaling $82.5 million with 10 groups. The estimated insurance recovery rate remains at approximately 25% of the liability.
Risks and Uncertainties:
- Estimates are based on historical data which may not predict future trends.
- Significant upward or downward trends in mesothelioma claims, settlement costs, or defense costs could materially change the liability.
- Adverse verdicts that withstand appeal or changes in case law/legislation could alter estimates.
- Financial viability of insurance carriers affects the recoverable asset value.
Investor Verification Checklist
- Verify the specific revenue and net income figures for the quarter ended September 30, 2014, by reviewing the attached Exhibit 99.1 (Press Release) and Exhibit 99.2 (Financial Supplement), as these are not detailed in the 8-K text.
- Monitor the status of the pending appeals for the Ronald Dummitt, Gerald Suttner, and James Nelson cases, as final judgments could impact future cash flows.
- Review the "coverage-in-place" agreements to understand the terms under which the 25% insurance recovery rate is calculated and the potential for changes in insurer solvency.
- Assess the impact of the $88 million current liability portion on the company's short-term liquidity and working capital.
- Track the number of new mesothelioma claims filed, as this is cited as a primary driver of the liability estimate.